Visit to Pyeongchang, Republic of Korea for the 7th Meeting of the Conference of Parties Serving as the Meeting of Parties to the Cartegena Protocol on Biosafety
PDF version

Back – to – office Report on
Visit to Pyeongchang, Republic of Korea for the 7th Meeting of the Conference of Parties Serving as the Meeting of Parties to the Cartegena Protocol on Biosafety, 29th September to 3rd October 2014 D. W. Miano,

                                              Background
The visit was made to attend the 7th Meeting of the Conference of Parties serving as the Meeting of Parties to the Cartegena Protocol on Biosafety (COP-MOP7).
The Cartegena Protocol The Cartagena Protocol on Biosafety is an international agreement on biosafety, which is a supplement to the Convention on Biological Diversity. The Protocol seeks to protect biological diversity from the potential risks that may be posed by the modern biotechnology, while recognizing the great potential the technology has on promotion of human well-being, particularly in meeting critical needs for food, agriculture and health care. The objective of the Protocol is to contribute to ensuring an adequate level of protection in the field of the safe transfer, handling and use of living modified organisms resulting from modern biotechnology that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health, and specifically focusing on transboundary movements. Since the adoption of the Protocol in the year 2000, countries that are parties to the protocol meet regularly to review its implementation and make decisions necessary to promote effective implementation. The meeting in Korea was the 7th of such meetings of parties (MOP) where countries that are parties to the Convention on Biological Diversity meet as a conference of parties (COP).


The agenda of COP-MOP7
A total of 14 agenda items were considered during COP-MOP7. As a scientist involved in the development of genetically modified products, I was requested to participate as a Kenyandelegate in the discussions.

The agenda items were;
1. Report of the Compliance Committee
2. Operation and activities of the Biosafety Clearing-House
3. Matters related to the financial mechanism and resources
4. Cooperation with other organizations, conventions and initiatives
5. Report of the Executive Secretary on the administration of the Protocol and budgetary
matters
6. Exchange of experiences and challenges in the implementation of the Protocol,
focusing on the integration of biosafety into national development plans and
programmes

7. Handling, transport, packaging and identification of living modified organisms
8. Nagoya – Kuala Lumpur Supplementary Protocol on Liability and Redress
9. Risk assessment and risk management
10. Socio-economic considerations
11. Monitoring and reporting
12. Assessment and review of the effectiveness of the Protocol
13. Unintentional trans-boundary movements and emergency measures
14. Contained use of living modified organisms

Meeting and Participations
The conference was divided into two working groups, and each party requested to send their delegates to each of the groups. I attended working group II which deliberate on agenda items 2, 4, 6, 7, 9, 13 and 14. The decisions made in the meetings are posted on the CBD website.
Dr Miano with some delegates from Kenya and Tanzania during the evening party the opening ceremony
Dr Miano with Prof Ogoyi (Director of Technical affairs of the Kenyan National Biosafety Authority) during one of the discussion sessions3 Dr Miano with Dr Roy Mugiira, Senior Director from the ministry of Education

Conclusion
It was a great honour to represent the country and the University in such a high level meeting. It was also a big learning experience especially being the first time to be involved in international negotiations, more so on issues of biosafety. The financial support from VIRCA Project and ISAAA is highly appreciated.

Date and time: 
Fri, 2014-10-17 16:15
Expiry Date: 
Fri, 2014-10-17 16:15
Contact Person: 

Dr. Miano

AttachmentSize
Miano Back-to-office report from COP-MOP7.pdf253.74 KB